What potential effect does the medication finasteride have on women of childbearing age?

Prepare for the APEA Pharmacology Women's Health Test with our comprehensive study materials. Utilize flashcards and multiple-choice questions, each with hints and detailed explanations. Get exam-ready now!

Multiple Choice

What potential effect does the medication finasteride have on women of childbearing age?

Explanation:
Finasteride is a medication primarily used to treat conditions like benign prostatic hyperplasia and male pattern baldness. In women of childbearing age, it poses a significant risk during pregnancy due to its potential teratogenic effects. Finasteride works by inhibiting the enzyme 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT). High levels of DHT are crucial for male genital development; if a female fetus is exposed to finasteride, it can lead to improper development of the genitalia and other congenital malformations. This teratogenic risk necessitates that women who are pregnant or may become pregnant avoid the medication. Due to these concerns, it is classified as a category X medication by the FDA, meaning that it is contraindicated during pregnancy due to the demonstrated risk of fetal harm. The other options do not accurately reflect the implications of finasteride use in women of childbearing age. Finasteride does not lead to increased fertility, and asserting that it has no effect on pregnancy or that it is safe for use without restrictions ignores the serious hazards associated with exposure during pregnancy. Therefore, the correct choice highlights the critical nature of understanding the risks finasteride presents to pregnant women or those who

Finasteride is a medication primarily used to treat conditions like benign prostatic hyperplasia and male pattern baldness. In women of childbearing age, it poses a significant risk during pregnancy due to its potential teratogenic effects. Finasteride works by inhibiting the enzyme 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT). High levels of DHT are crucial for male genital development; if a female fetus is exposed to finasteride, it can lead to improper development of the genitalia and other congenital malformations.

This teratogenic risk necessitates that women who are pregnant or may become pregnant avoid the medication. Due to these concerns, it is classified as a category X medication by the FDA, meaning that it is contraindicated during pregnancy due to the demonstrated risk of fetal harm.

The other options do not accurately reflect the implications of finasteride use in women of childbearing age. Finasteride does not lead to increased fertility, and asserting that it has no effect on pregnancy or that it is safe for use without restrictions ignores the serious hazards associated with exposure during pregnancy. Therefore, the correct choice highlights the critical nature of understanding the risks finasteride presents to pregnant women or those who

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy